Profile picture of Mark Pinkham

A/Prof Mark Pinkham

Profile picture of Mark Pinkham

BM, BCh, MA(Hons)(Oxon), FRANZCR

Radiation Oncologist
Call
Enquire
Referrals

I am a compassionate and detail-orientated specialist, aiming to deliver high-quality cancer care with a strong emphasis on multidisciplinary collaboration and clinical trials.

Biography

A/Prof Mark Pinkham is an experienced radiation oncologist and Adjunct Professor at Queensland University of Technology (QUT), consulting at Icon Cancer Centre North Lakes and Greenslopes Private Hospital. He is also a Senior Staff Specialist at the Gamma Knife Centre of Queensland at the Princess Alexandra Hospital where he is the Director of Radiation Oncology Research.

He graduated from The University of Oxford, UK, in 2005 and completed a Masters in Physiological Sciences with a focus on the neurosciences in 2002. Subsequently he completed specialist training in Brisbane in 2014 and then undertook an 18-month Clinical Oncology sub-specialty fellowship in neuro-oncology and intracranial stereotactic radiosurgery (SRS) at the world-renowned Christie Hospital, UK.

He has a strong research interest in melanoma and brain tumours, including brain metastases, and is involved in the management of several clinical trials. His work has focused on improving treatments, imaging and survivorship issues for patients affected by these diseases. He has published over 40 manuscripts and acquired over AU$12 million in competitive research grant funding to date. He is a member of the Scientific Advisory Committee within the Co-operative Trials Group for Neuro-Oncology (COGNO) and the inaugural Chair of the Brain Tumour (CNS) Working Party within TransTasman Radiation Oncology Group (TROG) across Australia and New Zealand.

He enjoys teaching through his roles as an examiner of medical trainees at the national level within the Royal Australian and New Zealand College of Radiologists (RANZCR) and supervisor to post-graduate research students at QUT and University of Queensland.

Research

Publications

  • Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes. Shanker, M. D., Garimall, S., Gatt, N., Foley, H., Crowley, S., Le Cornu, E., Muscat, K., Soon, W., Atkinson, V., Xu, W., Watkins, T., Huo, M., Foote, M. C., & Pinkham, M. B. Journal of medical imaging and radiation oncology, 2022; 66(4), 536–545.

  • Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery. Ghosh, S., Huda, P., Fletcher, N. L., Howard, C. B., Walsh, B., Campbell, D., Pinkham, M. B., & Thurecht, K. J. Molecular pharmaceutics, 2022; 19(5), 1233–1247.

  • Use of telehealth platforms for delivering supportive care to adults with primary brain tumors and their family caregivers: A systematic review. Ownsworth, T., Chan, R. J., Jones, S., Robertson, J., & Pinkham, M. B. Psycho-oncology, 2021; 30(1), 16–26.

  • Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases. Eitz, K. A., Lo, S. S., Soliman, H., Sahgal, A., Theriault, A., Pinkham, M. B., Foote, M. C., Song, A. J., Shi, W., Redmond, K. J., Gui, C., Kumar, A., Machtay, M., Meyer, B., & Combs, S. E. JAMA oncology, 2020; 6(12), 1901–1909.

  • Scoping the psychological support practices of Australian health professionals working with people with primary brain tumor and their families. Ownsworth, T., Lion, K., Sansom-Daly, U. M., Pike, K., Koh, E. S., Halkett, G., Pinkham, M. B., Chan, R. J., Dhillon, H. M., & BRAINS Program Investigators. Psycho-oncology, 2022.

Special Interests

A/Prof Mark Pinkham accepts referrals for all cancer types, with a special clinical interest in:

  • Brain and spine (CNS) cancer
  • Lung cancer
  • Melanoma
  • Palliative radiotherapy
  • Stereotactic radiation therapy

Languages spoken

  • English

Visiting Locations

  • Brisbane Private Hospital
  • Mater Private Hospital, South Brisbane
  • Princess Alexandra Hospital
  • St Andrews War Memorial Hospital
  • St Vincent’s Private Hospital, Northside
  • The Wesley Hospital

Affiliations & Memberships

  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • International Stereotactic Radiosurgery Society (ISRS)
  • Trans Tasman Radiation Oncology Group (TROG)
  • Cooperative Trials Group for Neuro-Oncology (COGNO)
  • Australia and New Zealand Melanoma Trials Group (ANZMTG)
  • Adjunct Professor, Queensland University of Technology (QUT)
  • Senior Lecturer, University of Queensland (UQ)

Publications

  • Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes. Shanker, M. D., Garimall, S., Gatt, N., Foley, H., Crowley, S., Le Cornu, E., Muscat, K., Soon, W., Atkinson, V., Xu, W., Watkins, T., Huo, M., Foote, M. C., & Pinkham, M. B. Journal of medical imaging and radiation oncology, 2022; 66(4), 536–545.

  • Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery. Ghosh, S., Huda, P., Fletcher, N. L., Howard, C. B., Walsh, B., Campbell, D., Pinkham, M. B., & Thurecht, K. J. Molecular pharmaceutics, 2022; 19(5), 1233–1247.

  • Use of telehealth platforms for delivering supportive care to adults with primary brain tumors and their family caregivers: A systematic review. Ownsworth, T., Chan, R. J., Jones, S., Robertson, J., & Pinkham, M. B. Psycho-oncology, 2021; 30(1), 16–26.

  • Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases. Eitz, K. A., Lo, S. S., Soliman, H., Sahgal, A., Theriault, A., Pinkham, M. B., Foote, M. C., Song, A. J., Shi, W., Redmond, K. J., Gui, C., Kumar, A., Machtay, M., Meyer, B., & Combs, S. E. JAMA oncology, 2020; 6(12), 1901–1909.

  • Scoping the psychological support practices of Australian health professionals working with people with primary brain tumor and their families. Ownsworth, T., Lion, K., Sansom-Daly, U. M., Pike, K., Koh, E. S., Halkett, G., Pinkham, M. B., Chan, R. J., Dhillon, H. M., & BRAINS Program Investigators. Psycho-oncology, 2022.

Search

Contact us
Become a patient